Advancements in pharmacotherapyparticularly glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agents (henceforth referred to as GLP-1 and GLP-1/GIP medications)have emerged as a promising tool for weight management
Pemvidutide, developed by Altimmune, is a GLP-1/glucagon dual agonist that has completed Phase 2 trials for obesity (MOMENTUM, 15.6% weight loss at 48 weeks) and MASH (IMPACT, up to 59.1% MASH resolution)
Other Ingredients: Purified Water, Glycerol, L-Carnitine, Xanthan Gum, Acidity Regulator (Citric Acid Monohydrate, Sodium Citrate), Preservative (Potassium Sorbate, Sodium Benzoate), Sweetener (Sucralose), Flavour (Raspberry), Colour (Carmoisine)
a 17% jump in immediate recall of categorized words